CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Net income			$ 7,725	$ 11,964
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			14,280	13,355
Provision for bad debt and credit losses			1,837	1,188
Stock-based compensation expense			2,473	1,616
Deferred income tax expense			4,750	1,270
Amortization of deferred financing costs			592	289
Amortization of capitalized commissions on preneed contracts	$ 145	$ 140	430	417
Accretion of discount on convertible subordinated notes	69	61	200	178
Accretion of debt discount, net of debt premium on senior notes			228	366
Net loss on divestitures and impairments charges			19,610	4,604
Net loss on sale of other assets			245	193
Gain on insurance reimbursements			(54)	(638)
Goodwill and other intangible asset impairments			6	0
Other			19	121
Changes in operating assets and liabilities that provided (required) cash:
Accounts and preneed receivables			(436)	(2,495)
Inventories, prepaid and other current assets			3,241	1,138
Intangible and other non-current assets			(225)	(241)
Preneed funeral and cemetery trust investments			(2,781)	(4,376)
Accounts payable			1,155	(3,852)
Accrued and other liabilities			9,770	6,749
Deferred preneed funeral and cemetery revenue			1,319	804
Deferred preneed funeral and cemetery receipts held in trust			3,438	3,411
Net cash provided by operating activities			67,822	36,061
Cash flows from investing activities:
Acquisitions			(28,011)	0
Proceeds from insurance reimbursements			97	1,247
Proceeds from divestitures and sale of other assets	7,300		7,416	967	$ 900
Capital expenditures			(10,034)	(11,479)
Net cash used in investing activities			(30,532)	(9,265)
Cash flows from financing activities:
Borrowings from the credit facility			89,300	28,200
Payments against the credit facility			(117,100)	(37,300)
Repurchase of the 2.75% convertible subordinated notes			(4,563)	(27)
Payment of transaction costs related to the repurchase of the 2.75% convertible subordinated notes			(12)	0
Payments of debt issuance costs related to the 6.625% senior notes			0	(113)
Payments on acquisition debt and obligations under finance leases			(1,060)	(1,370)
Payments on contingent consideration recorded at acquisition date			(169)	(162)
Proceeds from the exercise of stock options and employee stock purchase plan contributions			921	1,155
Taxes paid on restricted stock vestings and exercise of non-qualified options			(281)	(194)
Dividends paid on common stock			(4,251)	(4,061)
Purchase of treasury stock			0	(7,756)
Net cash used in financing activities			(37,281)	(21,628)
Net increase in cash and cash equivalents			9	5,168
Cash and cash equivalents at beginning of period		5,812	716	644	644
Cash and cash equivalents at end of period	725		725		$ 716
Senior Notes [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of deferred financing costs	72	35	208	103
Cash flows from financing activities:
Payments of debt issuance costs related to the 6.625% senior notes			(66)	0
Senior Notes [Member] | Senior Note Two [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of debt discount, net of debt premium on senior notes	56		165
Convertible Subordinated Notes [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of deferred financing costs	$ 9	$ 6	$ 21	$ 19